Compare OGN & CCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OGN | CCO |
|---|---|---|
| Founded | 1923 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Advertising |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.2B |
| IPO Year | 2020 | 2005 |
| Metric | OGN | CCO |
|---|---|---|
| Price | $13.72 | $2.40 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 5 | 3 |
| Target Price | ★ $11.25 | $2.43 |
| AVG Volume (30 Days) | 1.9M | ★ 4.2M |
| Earning Date | 11-09-2026 | 11-05-2026 |
| Dividend Yield | 0.58% | ★ 23.24% |
| EPS Growth | N/A | ★ 110.81 |
| EPS | ★ 0.95 | N/A |
| Revenue | ★ $6,216,000,000.00 | $1,604,140,000.00 |
| Revenue This Year | N/A | $7.33 |
| Revenue Next Year | $2.51 | $2.33 |
| P/E Ratio | $14.43 | ★ N/A |
| Revenue Growth | N/A | ★ 6.57 |
| 52 Week Low | $5.69 | $1.27 |
| 52 Week High | $13.79 | $2.44 |
| Indicator | OGN | CCO |
|---|---|---|
| Relative Strength Index (RSI) | 53.70 | 56.08 |
| Support Level | $13.46 | $2.37 |
| Resistance Level | $13.77 | $2.41 |
| Average True Range (ATR) | 0.04 | 0.02 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 59.09 | 81.25 |
Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.
Clear Channel Outdoor Holdings Inc is a provider of out-of-home advertising solutions. The company offers advertisers an opportunity to reach mass audiences across various high-traffic public spaces, by using its diverse portfolio of assets including roadside billboards, street furniture, and airport displays. Its reportable segments are; America (U.S. operations excluding airports), Airports (U.S. and Caribbean airport operations), and Other. A majority of its revenue is generated from the America segment which generates revenue from the sale of advertising on printed and digital out-of-home advertising displays such as bulletins, posters, street furniture, and others. Geographically, the company generates maximum revenue from the United States followed by Singapore.